今世緣(603369.SH):收回集合計劃投資本金及收益 其中累計取得收益4819.3萬元
格隆匯 12 月 10日丨今世緣(603369.SH)公佈,公司於2017年11月6日召開了第三屆董事會第八次會議,會議授權公司高管團隊使用不超過2.7億元閒置自有資金投資華泰資產管理有限公司運行的“華泰紫金易融寶5號集合資產管理計劃”(滾動投資,單次投資不超過0.9億元,有效期內任一時點實際投資餘額不超過2.7億元)。
近日,上述集合計劃進入清算,公司收回上述集合計劃投資本金及收益,其中收回全部本金2.7億元,累計取得收益4819.30萬元,實際取得的年化收益率約為5.92%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.